Zimmer Biomet Holdings has seen only a modest tweak to its fair value estimate, shifting from US$102.65 to US$103.00, which keeps the core valuation story largely intact. That kind of incremental ...
The deal would effectively double the company's $5.6 billion valuation in just four months.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results